EchoGo® Heart Failure vs uOmnispace.MI
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is a specialized AI platform for detecting HFpEF from echocardiograms, offering rapid diagnostic insights. Tool B is a broader medical imaging software providing comprehensive 2D/3D viewing and AI-enhanced analysis across multiple modalities like PET, CT, MR, and SPECT for various clinical workflows. While both leverage AI in cardiology, Tool A focuses on a specific diagnostic challenge with ultrasound, whereas Tool B offers general-purpose advanced imaging analysis across different modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform specifically designed to analyze routine echocardiograms for the detection of Heart Failure with preserved Ejection Fraction (HFpEF), providing insights to support clinical decisions. In contrast, uOmnispace.MI is an advanced medical imaging software that offers comprehensive 2D and 3D viewing, AI-enhanced segmentation, and analysis tools for various modalities like PET, CT, MR, and SPECT, supporting clinical workflows across oncology, neurology, and cardiology.
EchoGou00ae Heart Failure exclusively analyzes routine echocardiograms, specifically 2D echocardiograms with an apical 4-chamber view. uOmnispace.MI supports a broader range of imaging modalities, including PET, CT, MR, and SPECT images.
EchoGou00ae Heart Failure utilizes AI specifically for HFpEF detection, offering a classification result and a probability score to aid in diagnosis. uOmnispace.MI provides AI-enhanced segmentation capabilities, such as rib extraction, along with other AI-powered quantitative analysis and deep learning algorithms for features like spine and rib labeling, brain scan quantification, and cardiac function analysis.
Yes, EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. It is also covered in the hospital inpatient setting under the New Technology Add-on Payment (NTAP) code XXE2X19. For uOmnispace.MI, pricing is available by contacting the vendor, and no specific reimbursement codes are mentioned in the provided information.
EchoGou00ae Heart Failure is designed to deliver insights for HFpEF detection within 20 minutes, supporting timely clinical decision-making. The provided information for uOmnispace.MI does not specify a turnaround time for its analysis features.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection, and has been rigorously validated in studies, including one at Beth Israel Deaconess Medical Center. uOmnispace.MI utilizes deep learning-based algorithms with performance validation conducted on large, diverse datasets to ensure high accuracy and robustness across subgroups for features like spine and rib labeling.